Global Erectile Dysfunction Market 2018-2023 - Mar
Post# of 350
(Total Views: 406)
Posted On: 05/04/2018 1:38:38 PM
Global Erectile Dysfunction Market 2018-2023 - Market to Reach $4.25 Billion - ResearchAndMarkets.com
February 13, 2018 02:21 PM Eastern Standard Time
DUBLIN--(BUSINESS WIRE)--The "Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
“Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023”
Tweet this
According to the latest industry analysis, the size of the global erectile dysfunction market is expected to reach $4.25 billion by 2023.
This market research report offers analysis on market size and forecast, market share, industry trends, growth drivers, and vendor analysis. The study also includes insights on segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America).
Increasing disease awareness, growing patient willingness to seek medical assistance for disease management, and the increasing presence of favorable guidelines are driving the growth of the erectile dysfunction market. The three most popular erectile dysfunction drugs that are available in the market are ED oral drugs, Viagra, Cialis, and Levitra. The global erectile dysfunction market is also witnessing a rising demand for low-cost generic drugs, especially in the APAC countries such as Indian and China.
The study covers a detailed overview of various market growth enablers, restraints, and trends. It covers both the demand and supply sides of the market. The study also profiles and analyzes the top six leading companies and 12 other prominent companies operating in the market.
Major Vendors
Bayer AGEli Lilly and CompanyVIVUS Inc.PfizerBoston Scientific Corp.Coloplast A/S
Prominent Players
Apricus Biosciences Inc.
Endo International
PlcFutura Medical
Premedon
Teva Pharmaceutical Industries Limited (Teva)
Zephyr Surgical Implants (ZSI)
Augusta Medical Systems LLC (Augusta Medical)
Post-T-Vac Medical
Bonro Medical
Cristalia Produtos Quimicos Farmaceuticos Ltd.
SK Chemicals
https://www.businesswire.com/news/home/201802...3---Market
Many of these companies will be at the AUA.
http://s23.a2zinc.net/clients/AUA/AUA2018/Pub...x?shMode=E
http://www.aua2018.org/attendee-info?search=S...=0&y=0
Aloha
February 13, 2018 02:21 PM Eastern Standard Time
DUBLIN--(BUSINESS WIRE)--The "Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
“Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023”
Tweet this
According to the latest industry analysis, the size of the global erectile dysfunction market is expected to reach $4.25 billion by 2023.
This market research report offers analysis on market size and forecast, market share, industry trends, growth drivers, and vendor analysis. The study also includes insights on segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America).
Increasing disease awareness, growing patient willingness to seek medical assistance for disease management, and the increasing presence of favorable guidelines are driving the growth of the erectile dysfunction market. The three most popular erectile dysfunction drugs that are available in the market are ED oral drugs, Viagra, Cialis, and Levitra. The global erectile dysfunction market is also witnessing a rising demand for low-cost generic drugs, especially in the APAC countries such as Indian and China.
The study covers a detailed overview of various market growth enablers, restraints, and trends. It covers both the demand and supply sides of the market. The study also profiles and analyzes the top six leading companies and 12 other prominent companies operating in the market.
Major Vendors
Bayer AGEli Lilly and CompanyVIVUS Inc.PfizerBoston Scientific Corp.Coloplast A/S
Prominent Players
Apricus Biosciences Inc.
Endo International
PlcFutura Medical
Premedon
Teva Pharmaceutical Industries Limited (Teva)
Zephyr Surgical Implants (ZSI)
Augusta Medical Systems LLC (Augusta Medical)
Post-T-Vac Medical
Bonro Medical
Cristalia Produtos Quimicos Farmaceuticos Ltd.
SK Chemicals
https://www.businesswire.com/news/home/201802...3---Market
Many of these companies will be at the AUA.
http://s23.a2zinc.net/clients/AUA/AUA2018/Pub...x?shMode=E
http://www.aua2018.org/attendee-info?search=S...=0&y=0
Aloha
(0)
(0)Creative Medical Technology Holdings Inc (CELZ) Stock Research Links
Scroll down for more posts ▼